Pharmaceutical Capsule Supply – Benzonatate 100 MG

The contract seeks the supply of FDA-compliant Benzonatate 100 MG capsules in bottles containing 100 units each, with full packaging, labeling, and shipment logistics included to a U.S. military facility located in Germany. All products must meet stringent regulatory standards for safety and quality, ensuring compliance with U.S. Food and Drug Administration requirements, and the labeling must adhere to military and federal specifications for international distribution. The scope encompasses end-to-end fulfillment from manufacturing through delivery, requiring the contractor to manage all aspects of quality control, documentation, and transportation under strict conditions suitable for pharmaceuticals destined for government use. The solicitation is categorized as a subcontract under NAICS code 325412, indicating pharmaceutical and medicine manufacturing, and was posted on August 3, 2026, with a response deadline of August 10, 2026. The contracting agency is the Medical Supply Chain Pharm FSA under the Department of Defense, underscoring the critical nature of this supply for military healthcare operations. Although the exact location within Germany is not specified, delivery must reach the designated military facility in compliance with defense logistics protocols. Potential bidders are directed to the DIBBS portal for detailed submission requirements and must ensure full alignment with all regulatory, packaging, and timing obligations outlined in the solicitation.